Free 2 day AUS and US shipping for orders above $200 • Register for an account to receive 20% off

MOTS-C 10mg

$55.00

MOTS-C (mitochondrial open reading frame of the 12S rRNA type-c) is a novel mitochondrial-derived peptide (MDP). It is a short, non-glycosylated polypeptide chain consisting of 16 amino acids. MOTS-C is expressed in various tissues and in circulation (plasma) in rodents and humans, suggesting both a cell-autonomous and hormonal role. It is mainly activated by stress and exercise, while its expression decreases with aging. The identification of MOTS-C as a mitochondrial-derived peptide opens new avenues for understanding and influencing cellular bioenergetics. Its broad impact on metabolism, aging, and neuroprotection positions it as a compelling component for a gut-brain product aiming to enhance cellular health and resilience across multiple physiological systems.

This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.

In Stock

Data Sheet

Molecular Formula C₁₀₁H₁₅₂N₂₈O₂₂S₂
CAS Number 1627580-64-6
Molar Mass 2174.60 g/mol
Amino Acid Sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
PubChem CID 146675088
Primary Research Area Metabolic Actions
Skeletal Muscle Glucose Metabolism
Obesity & Diabetes Regulation
Exercise & Longevity
Insulin Resistance
Stress Adaptation
Anti-inflammatory Processes
Neuroprotection
Aging-Related Pathologies
Brown Adipose Tissue (BAT) Activation
Purity >99%
Research Summary Description
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces insulin resistance Summary: This study highlighted MOTS-C's significant role in glucose metabolism. It targets skeletal muscle to enhance glucose uptake and has implications for obesity, diabetes, exercise, and longevity.

Citation: Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J.,... & Cohen, P. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces insulin resistance. Cell Metabolism, 21(1), 113-124.
A cell-penetrating MOTS-c analogue enhances memory and attenuates neuroinflammation in the hippocampus Summary: Investigations have shown MOTS-C exhibiting anti-inflammatory effects by modulating key molecules like AMPK, SIRT1, and NF-κB, and by inhibiting reactive oxygen species (ROS) production. Furthermore, a cell-penetrating MOTS-C analogue has been shown to enhance memory and attenuate neuroinflammation in the hippocampus.

Citation: Jiang, L., Li, Y., Li, X., Wang, Y., & Zhang, Y. (2021). A cell-penetrating MOTS-c analogue enhances memory and attenuates neuroinflammation in the hippocampus. Journal of Neuroinflammation, 18(1), 1-15.
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis Summary: This study investigated the role of MOTS-c in physical performance and aging. It demonstrated that MOTS-c levels in both human skeletal muscle and circulation are increased by exercise. In mice, exogenous administration of MOTS-c improved exercise capacity, grip strength, and protected against age-dependent physical decline. It also influenced muscle metabolism and gene expression, promoting a more youthful metabolic profile in aged muscles. These effects were linked to its role in regulating metabolic pathways crucial for muscle function and resilience.

Citation:
Reynolds, J. C., Jo, Y. S., Palmer, C. S., Lee, C., & Cohen, P. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 12(1), 470. https://doi.10388/s41467-020-20790-0
MOTS-c reduces myostatin and muscle atrophy signaling Summary: This study explored the relationship between MOTS-c and myostatin, a well-known negative regulator of muscle growth. The researchers found an inverse correlation between plasma MOTS-c and myostatin levels in humans. In animal models, MOTS-c treatment was shown to reduce myostatin expression and activity, as well as downstream signaling pathways associated with muscle atrophy (e.g., SMAD2/3 phosphorylation and atrogene expression). This suggests a mechanism by which MOTS-c could counteract muscle wasting.

Citation:
Fuku, M., Ohno, R., Kono, J., Kim, K. H., Cohen, P., & Ishii, M. (2021). MOTS-c reduces myostatin and muscle atrophy signaling. FASEB Journal, 35(6), e21550. https://doi.org/10.1096/fj.202002570R
Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging Summary: MOTS-C is recognized for its role in maintaining energy and stress homeostasis, thereby promoting healthy aging. Its expression decreases with aging, suggesting that its decline may contribute to age-related physiological changes.

Citation: Reynolds, J. C., Lee, C., & Cohen, P. (2021). Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. Aging Cell, 20(1), e13292.
"Mitochondrial-encoded peptide MOTS-c, diabetes, and aging-related diseases " Summary: This review article summarizes the therapeutic potential of MOTS-c in diabetes and age-related diseases. It highlights MOTS-c's ability to regulate T-cell differentiation and activation (e.g., upregulation of Treg cells) in an mTORC1-dependent manner. This immunoregulatory function was shown to prevent pancreatic infiltration of autoreactive T-cells in non-obese diabetic (NOD) mice, a model for type 1 diabetes. MOTS-c also improved glucose tolerance and insulin secretion and protected pancreatic beta-cells. The review further discusses MOTS-c's broader impact on metabolic adaptability and age-related conditions.

Citation:
Kim, H., & Lee, J. Y. (2023). Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases. Diabetes & Metabolism Journal, 47(2), 143–153. https://doi.org/10.4093/dmj.2022.0360

The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces insulin resistance

Summary: This study highlighted MOTS-C's significant role in glucose metabolism. It targets skeletal muscle to enhance glucose uptake and has implications for obesity, diabetes, exercise, and longevity.

Citation: Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J.,... & Cohen, P. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces insulin resistance. Cell Metabolism, 21(1), 113-124.

A cell-penetrating MOTS-c analogue enhances memory and attenuates neuroinflammation in the hippocampus

Summary: Investigations have shown MOTS-C exhibiting anti-inflammatory effects by modulating key molecules like AMPK, SIRT1, and NF-κB, and by inhibiting reactive oxygen species (ROS) production. Furthermore, a cell-penetrating MOTS-C analogue has been shown to enhance memory and attenuate neuroinflammation in the hippocampus.

Citation: Jiang, L., Li, Y., Li, X., Wang, Y., & Zhang, Y. (2021). A cell-penetrating MOTS-c analogue enhances memory and attenuates neuroinflammation in the hippocampus. Journal of Neuroinflammation, 18(1), 1-15.

MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis

Summary: This study investigated the role of MOTS-c in physical performance and aging. It demonstrated that MOTS-c levels in both human skeletal muscle and circulation are increased by exercise. In mice, exogenous administration of MOTS-c improved exercise capacity, grip strength, and protected against age-dependent physical decline. It also influenced muscle metabolism and gene expression, promoting a more youthful metabolic profile in aged muscles. These effects were linked to its role in regulating metabolic pathways crucial for muscle function and resilience.

Citation:
Reynolds, J. C., Jo, Y. S., Palmer, C. S., Lee, C., & Cohen, P. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 12(1), 470. https://doi.10388/s41467-020-20790-0

MOTS-c reduces myostatin and muscle atrophy signaling

Summary: This study explored the relationship between MOTS-c and myostatin, a well-known negative regulator of muscle growth. The researchers found an inverse correlation between plasma MOTS-c and myostatin levels in humans. In animal models, MOTS-c treatment was shown to reduce myostatin expression and activity, as well as downstream signaling pathways associated with muscle atrophy (e.g., SMAD2/3 phosphorylation and atrogene expression). This suggests a mechanism by which MOTS-c could counteract muscle wasting.

Citation:
Fuku, M., Ohno, R., Kono, J., Kim, K. H., Cohen, P., & Ishii, M. (2021). MOTS-c reduces myostatin and muscle atrophy signaling. FASEB Journal, 35(6), e21550. https://doi.org/10.1096/fj.202002570R

Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging

Summary: MOTS-C is recognized for its role in maintaining energy and stress homeostasis, thereby promoting healthy aging. Its expression decreases with aging, suggesting that its decline may contribute to age-related physiological changes.

Citation: Reynolds, J. C., Lee, C., & Cohen, P. (2021). Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. Aging Cell, 20(1), e13292.

"Mitochondrial-encoded peptide MOTS-c, diabetes, and aging-related diseases "

Summary: This review article summarizes the therapeutic potential of MOTS-c in diabetes and age-related diseases. It highlights MOTS-c's ability to regulate T-cell differentiation and activation (e.g., upregulation of Treg cells) in an mTORC1-dependent manner. This immunoregulatory function was shown to prevent pancreatic infiltration of autoreactive T-cells in non-obese diabetic (NOD) mice, a model for type 1 diabetes. MOTS-c also improved glucose tolerance and insulin secretion and protected pancreatic beta-cells. The review further discusses MOTS-c's broader impact on metabolic adaptability and age-related conditions.

Citation:
Kim, H., & Lee, J. Y. (2023). Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases. Diabetes & Metabolism Journal, 47(2), 143–153. https://doi.org/10.4093/dmj.2022.0360

All content and product details on this website are provided solely for informational and educational purposes.

View Cart (0 items)

Your cart is empty

Start Shopping